Jean-Maurice Dumonts
Corporate Officer/Principal at Debiopharm International SA
Network origin in Jean-Maurice Dumonts first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
University of Lyon
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Maurice Dumonts via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Lausanne | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin | |
Debiopharm Innovation Fund /Management/
 Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Investment Managers | Director/Board Member Chief Executive Officer | |
| Swiss Federal Institute of Technology | College/University | Masters Business Admin Undergraduate Degree | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member | |
Med Discovery SA
 Med Discovery SA BiotechnologyHealth Technology Med Discovery SA is a Swiss biopharmaceutical company that develops treatments for cancers. The private company was founded by David Luc Deperthes. | Biotechnology | Founder | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
| CATERPILLAR INC. | Trucks/Construction/Farm Machinery | Corporate Officer/Principal | |
| BOBST GROUP SA | Industrial Machinery | Human Resources Officer | |
| Mercuri Urval AG | Corporate Officer/Principal | ||
| Haute école spécialisée de Suisse occidentale University | College/University | Undergraduate Degree | |
| Institut d’Administration des Entreprises | College/University | Masters Business Admin | |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| BTG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Kiel | College/University | Doctorate Degree | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BERGENBIO ASA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NUCANA PLC | Biotechnology | Chief Operating Officer | |
| VIRAX BIOLABS GROUP LIMITED | Financial Conglomerates | Chief Operating Officer | |
| University of Strathclyde | College/University | Undergraduate Degree | |
| University of Warwick | College/University | Doctorate Degree | |
| University of Fribourg | College/University | Doctorate Degree | |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The State University of New York | College/University | Corporate Officer/Principal | |
| ONCODESIGN | Biotechnology | Director/Board Member | |
| ONCODESIGN PRECISION MEDICINE | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Centre d'Immunologie Pierre Fabre | Corporate Officer/Principal | ||
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia. | Medical Specialties | Director/Board Member | |
| Universidad del Rosario | College/University | Doctorate Degree | |
| University of Bern | College/University | Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Goldrush Resources Ltd.
 Goldrush Resources Ltd. Precious MetalsNon-Energy Minerals Goldrush Resources Ltd. engages in the provision of mineral exploration. Its activities include acquisition, development and exploration of mineral resources interests in Burkina Faso, West Africa. The company was founded on January 21, 1966 and is headquartered in Vancouver, Canada. | Precious Metals | Corporate Officer/Principal | |
| gXe-csa Consultant | President | ||
| University of Geneva | College/University | Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| Debio Recherche Pharmaceutique SA | President | ||
| King's College London | College/University | Graduate Degree |
Statistics
International
| Switzerland | 17 |
| France | 11 |
| United Kingdom | 7 |
| United States | 6 |
| Ireland | 3 |
Sectoral
| Consumer Services | 19 |
| Health Technology | 14 |
| Finance | 4 |
| Health Services | 4 |
| Commercial Services | 3 |
Operational
| Corporate Officer/Principal | 25 |
| Director/Board Member | 16 |
| Chief Tech/Sci/R&D Officer | 7 |
| Doctorate Degree | 7 |
| Undergraduate Degree | 6 |
Most connected contacts
- Stock Market
- Insiders
- Jean-Maurice Dumonts
- Company connections
